Lobbying registration dated 2026-02-26
Registrant: Pamela Valentine
Client: MS Canada
Targeted institutions:
Atlantic Canada Opportunities Agency (ACOA)
Service Canada (ServCan)
Canadian Institutes of Health Research (CIHR)
Treasury Board Of Canada Secretariat (TBS)
Public Services and Procurement Canada (PSPC)
Office of the Federal Housing Advocate
Office of the Information Commissioner of Canada (OIC)
Global Affairs Canada (GAC)
Patented Medicine Prices Review Board (PMPRB)
Transport Canada (TC)
Canada Post Corporation (CPC)
Canadian Heritage (PCH)
Canada Employment Insurance Commission
Women and Gender Equality (WAGE)
Finance Canada (FIN)
Social Sciences and Humanities Research Council (SSHRC)
Canadian Transportation Agency (CTA)
House of Commons
Office of the Commissioner of Lobbying (OCL)
Canadian Human Rights Commission (CHRC)
Statistics Canada (StatCan)
Rural Economic Development (Minister’s Office)
Employment and Social Development Canada (ESDC)
Veterans Affairs Canada (VAC)
Canada Revenue Agency (CRA)
Office of the Privacy Commissioner of Canada (OPC)
Public Health Agency of Canada (PHAC)
Privy Council Office (PCO)
Senate of Canada
Health Canada (HC)
Prime Minister's Office (PMO)
Innovation, Science and Economic Development Canada (ISED)
Accessibility Standards Canada
Legislative bills: C-64
Acts: Canada Pension Plan
Canada Health Act
Government funding received:
Institution: Government of Alberta - Alberta Gaming - Community Initiative Program (Friendly Visiting)
Amount: 142598.00
Institution: BC Provincial Health Services Authority (PHSA)
Amount: 66143.00
Lobbying activity details:
Federal Budget: Allocate funding for the Canada Disability Benefit, the Employment Insurance Sickness Benefit; health research; access to treatment and care; and other budgetary policy as it relates to MS.
Access to treatments as it relates to the current regulatory and price negotiation processes to enhance timely access to all Health Canada approved MS disease-modifying therapies, with respect to the National Strategy for Drugs for Rare Diseases and national pharmacare.
Postal service disruption and the
significant hardships these disruptions cause for Canadians and on health charities
CIHR as it relates to federal funding & long term investment in health research
Canada Health Transfer - health system funding transfer and agreements intended for provinces/territories to support the delivery of healthcare services, including MS care
We ask the federal government to fund MS research in partnership with MS Canada, leveraging our connections and expertise to focus and further our understanding of MS, pursue leading-edge research on repair and regeneration, and explore prevention strategies, including targeting the Epstein-Barr virus (EBV).
Measures and funding for the charitable sector generally
Safe Long-Term Care Act with respect to persons affected by MS
Bill C-64, An Act Respecting Pharmacare with respect for persons with MS and other chronic conditions and disabilities
Canada Health Act and regulations, as it relates to long-term and home care
Disability Tax Credit with respect to making it refundable and ensuring eligibility for Canadians with episodic disabilities
Canada Pension Plan – Disability with respect to eligibility for persons with MS and other chronic and episodic disabilities
Employment Insurance sickness benefits, with respect to creation of flexible benefits for persons with MS and other episodic disabilities
Home care, with respect to creation with provincial/ territorial governments programs relating to increased home care for persons with MS and other disabilities/ diseases and the support of caregivers
National Housing Strategy with respect for persons with MS and other chronic conditions and disabilities
Comprehensive disability income programs, with respect to persons with MS and other chronic and episodic disabilities
Establishment of national strategy for neurological conditions, with respect to persons with MS and other neurological conditions.